![]() |
Volumn 33, Issue 1, 2001, Pages 29-34
|
Randomized, double-blind, controlled study of cefoperazone-sulbactam plus cotrimoxazole versus ceftazidime plus cotrimoxazole for the treatment of severe melioidosis
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CEFTAZIDIME;
COTRIMOXAZOLE;
SULPERAZON;
ADULT;
ARTICLE;
BACTERIUM CULTURE;
BLOOD CULTURE;
BURKHOLDERIA PSEUDOMALLEI;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG TOLERABILITY;
FEMALE;
HUMAN;
KIDNEY FAILURE;
MAJOR CLINICAL STUDY;
MALE;
MELIOIDOSIS;
MORTALITY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SEPTIC SHOCK;
STATISTICAL ANALYSIS;
ADULT;
AGED;
ANTI-BACTERIAL AGENTS;
BURKHOLDERIA PSEUDOMALLEI;
CEFOPERAZONE;
CEFTAZIDIME;
DOUBLE-BLIND METHOD;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
MALE;
MELIOIDOSIS;
MIDDLE AGED;
PROSPECTIVE STUDIES;
SULBACTAM;
TREATMENT OUTCOME;
TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;
|
EID: 0034979733
PISSN: 10584838
EISSN: None
Source Type: Journal
DOI: 10.1086/320878 Document Type: Article |
Times cited : (41)
|
References (14)
|